130 related articles for article (PubMed ID: 9358933)
1. Quality of life assessment in patients receiving adjuvant therapy for breast cancer: the IBCSG approach. The International Breast Cancer Study Group.
Bernhard J; Hürny C; Coates AS; Peterson HF; Castiglione-Gertsch M; Gelber RD; Goldhirsch A; Senn HJ; Rudenstam CM
Ann Oncol; 1997 Sep; 8(9):825-35. PubMed ID: 9358933
[TBL] [Abstract][Full Text] [Related]
2. Timing of baseline quality of life assessment in an international adjuvant breast cancer trial: its effect on patient self-estimation. The International Breast Cancer Study Group.
Hürny C; Bernhard J; Coates A; Castiglione M; Peterson HF; Gelber RD; Rudenstam CM; Goldhirsch A; Senn HJ
Ann Oncol; 1994 Jan; 5(1):65-74. PubMed ID: 8172795
[TBL] [Abstract][Full Text] [Related]
3. Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer. International Breast Cancer Study Group.
Hürny C; Bernhard J; Coates AS; Castiglione-Gertsch M; Peterson HF; Gelber RD; Forbes JF; Rudenstam CM; Simoncini E; Crivellari D; Goldhirsch A; Senn HJ
Lancet; 1996 May; 347(9011):1279-84. PubMed ID: 8622502
[TBL] [Abstract][Full Text] [Related]
4. Quality of life assessment in the International Breast Cancer Study Group: past, present, and future.
Hürny C; Bernhard J; Coates A
Recent Results Cancer Res; 1998; 152():390-5. PubMed ID: 9928574
[TBL] [Abstract][Full Text] [Related]
5. Factors affecting baseline quality of life in two international adjuvant breast cancer trials. International Breast Cancer Study Group (IBCSG).
Bernhard J; Hürny C; Coates AS; Peterson HF; Castiglione-Gertsch M; Gelber RD; Galligioni E; Marini G; Thürlimann B; Forbes JF; Goldhirsch A; Senn HJ; Rudenstam CM
Br J Cancer; 1998 Sep; 78(5):686-93. PubMed ID: 9744512
[TBL] [Abstract][Full Text] [Related]
6. Quality of life measures for patients receiving adjuvant therapy for breast cancer: an international trial. The International Breast Cancer Study Group.
Hürny C; Bernhard J; Gelber RD; Coates A; Castiglione M; Isley M; Dreher D; Peterson H; Goldhirsch A; Senn HJ
Eur J Cancer; 1992; 28(1):118-24. PubMed ID: 1567662
[TBL] [Abstract][Full Text] [Related]
7. Quality of life assessment in International Breast Cancer Study Group (IBCSG) trials: practical issues and factors associated with missing data.
Bernhard J; Peterson HF; Coates AS; Gusset H; Isley M; Hinkle R; Gelber RD; Castiglione-Gertsch M; Hürny C
Stat Med; 1998 Mar 15-Apr 15; 17(5-7):587-601. PubMed ID: 9549808
[TBL] [Abstract][Full Text] [Related]
8. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
9. Quality-of-life scores predict outcome in metastatic but not early breast cancer. International Breast Cancer Study Group.
Coates AS; Hürny C; Peterson HF; Bernhard J; Castiglione-Gertsch M; Gelber RD; Goldhirsch A
J Clin Oncol; 2000 Nov; 18(22):3768-74. PubMed ID: 11078489
[TBL] [Abstract][Full Text] [Related]
10. Responsiveness of a single-item indicator versus a multi-item scale: assessment of emotional well-being in an international adjuvant breast cancer trial.
Hürny C; Bernhard J; Coates A; Peterson HF; Castiglione-Gertsch M; Gelber RD; Rudenstam CM; Collins J; Lindtner J; Goldhirsch A; Senn HJ
Med Care; 1996 Mar; 34(3):234-48. PubMed ID: 8628043
[TBL] [Abstract][Full Text] [Related]
11. Quality of life as subjective experience: reframing of perception in patients with colon cancer undergoing radical resection with or without adjuvant chemotherapy. Swiss Group for Clinical Cancer Research (SAKK).
Bernhard J; Hürny C; Maibach R; Herrmann R; Laffer U
Ann Oncol; 1999 Jul; 10(7):775-82. PubMed ID: 10470423
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group.
Coates A; Gebski V; Signorini D; Murray P; McNeil D; Byrne M; Forbes JF
J Clin Oncol; 1992 Dec; 10(12):1833-8. PubMed ID: 1453197
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93.
; Rudenstam CM; Zahrieh D; Forbes JF; Crivellari D; Holmberg SB; Rey P; Dent D; Campbell I; Bernhard J; Price KN; Castiglione-Gertsch M; Goldhirsch A; Gelber RD; Coates AS
J Clin Oncol; 2006 Jan; 24(3):337-44. PubMed ID: 16344321
[TBL] [Abstract][Full Text] [Related]
14. When do patient reported quality of life indicators become prognostic in breast cancer?
Lee CK; Hudson M; Simes J; Ribi K; Bernhard J; Coates AS
Health Qual Life Outcomes; 2018 Jan; 16(1):13. PubMed ID: 29329582
[TBL] [Abstract][Full Text] [Related]
15. Quality of life evolution in elderly survivors with localized breast cancer treated with radiotherapy over a three-year follow-up.
Arraras JI; Manterola A; Illarramendi JJ; Asin G; de la Cruz S; Ibañez B; Galbete A; Salgado E; Zarandona U; Vera R; Dominguez MA; Martinez E
Breast; 2018 Oct; 41():74-81. PubMed ID: 30007271
[TBL] [Abstract][Full Text] [Related]
16. The Perceived Adjustment to Chronic Illness Scale (PACIS): a global indicator of coping for operable breast cancer patients in clinical trials. Swiss Group for Clinical Cancer Research (SAKK) and the International Breast Cancer Study Group (IBCSG).
Hürny C; Bernhard J; Bacchi M; van Wegberg B; Tomamichel M; Spek U; Coates A; Castiglione M; Goldhirsch A; Senn HJ
Support Care Cancer; 1993 Jul; 1(4):200-8. PubMed ID: 8193882
[TBL] [Abstract][Full Text] [Related]
17. Quality-of-life-adjusted evaluation of adjuvant therapies for operable breast cancer. The International Breast Cancer Study Group.
Gelber RD; Goldhirsch A; Cavalli F
Ann Intern Med; 1991 Apr; 114(8):621-8. PubMed ID: 2003707
[TBL] [Abstract][Full Text] [Related]
18. Quality of life assessment in the adjuvant setting: is it relevant? International Breast Cancer Study Group.
Gelber RD; Bonetti M; Cole BF; Gelber S; Goldhirsch A
Recent Results Cancer Res; 1998; 152():373-89. PubMed ID: 9928573
[TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of single item quality of life indicators in cancer clinical trials.
Bernhard J; Sullivan M; Hürny C; Coates AS; Rudenstam CM
Br J Cancer; 2001 May; 84(9):1156-65. PubMed ID: 11336464
[TBL] [Abstract][Full Text] [Related]
20. The best available adjuvant treatments are within the framework of clinical trials. The International Breast Cancer Study Group.
Goldhirsch A; Gelber RD; Castiglione M; Price KN; Rudenstam CM; Lindtner J; Collins J; Senn HJ; Cavalli F; Galligioni E
Isr J Med Sci; 1995; 31(2-3):144-54. PubMed ID: 7744584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
